3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Conditions
Paraparesis, Tropical Spastic
1
Opportunistic Infections
1
Neuritis
1
Leukemia-Lymphoma, Adult T-Cell
1
Inflammation
1
HTLV-I Infections
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Coinfection
1
Acquired Immunodeficiency Syndrome
1
Interventions
Valganciclovir
3
Valacyclovir
2
Polymerase Chain Reaction
2
Flow Cytometry
2
Cell Count
2
Blood Specimen Collection
2
letermovir
1
dolutegravir
1
Zidovudine
1
VCL-CB01 vaccine
1
Stem Cell Transplantation
1
Specimen Handling
1
Ritonavir
1
Peripheral Blood Stem Cell Transplantation
1
Nucleosides
1
Immunologic Techniques
1
Ganciclovir
1
Darunavir
1
Acyclovir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cytomegalovirus Infections
×
dolutegravir
×
Clear all
NCT04183738
2020-11-10
i2-D²EFT
Kirby Institute
Phase 4
Withdrawn